Guobang Pharma Ltd Class A 605507
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 16.05
- Price/Sales
- 1.86
- Dividend Yield (Trailing)
- 1.65%
- Dividend Yield (Forward)
- 1.65%
- Total Yield
- 1.65%
Company Profile
Guobang Pharma Ltd is engaged in the research and development, production and sales of related products in the field of medicine and animal health products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 4,231
- Website
- http://www.gbgcn.com
Comparables
Valuation
|
Metric
|
605507
|
600713
|
000919
|
|---|---|---|---|
Price/Earnings (Normalized) | 16.05 | 10.11 | 56.62 |
Price/Book Value | 1.35 | 0.92 | 1.03 |
Price/Sales | 1.86 | 0.11 | 1.16 |
Price/Cash Flow | 9.55 | 4.18 | 15.12 |
Price/Earnings
605507
600713
000919
Financial Strength
|
Metric
|
605507
|
600713
|
000919
|
|---|---|---|---|
Quick Ratio | 1.38 | 1.09 | 3.28 |
Current Ratio | 2.26 | 1.44 | 3.61 |
Interest Coverage | 26.39 | 4.34 | 388.44 |
Quick Ratio
605507
600713
000919
Profitability
|
Metric
|
605507
|
600713
|
000919
|
|---|---|---|---|
Return on Assets (Normalized) | 6.27% | 2.45% | 1.25% |
Return on Equity (Normalized) | 8.52% | 11.96% | 1.83% |
Return on Invested Capital (Normalized) | 7.37% | 6.16% | 1.04% |
Return on Assets
605507
600713
000919
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Hzvmdxbz | Qlpqx | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Dkbvsgtns | Szrjbnx | $77.4 Bil | |||
| Haleon PLC ADR
HLN
| Gpnqmyc | Qbbx | $47.3 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Vjzwjhczf | Sfmhg | $19.0 Bil | |||
| Viatris Inc
VTRS
| Ybtsndt | Bchk | $13.9 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Sjjcwqm | Xgl | $13.4 Bil | |||
| Catalent Inc
CTLT
| Zlzntpprb | Tphmmwp | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Kcymrywlg | Tptwtf | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Tmtlhsvj | Hvr | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Slfdcncht | Mjk | $2.5 Bil |
United States